The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

MP Advisors Reports

Overview Within the oral mucosal cavity, the buccal region offers an attractive route of administration for systemic drug delivery. The mucosa has a rich blood supply and it is relatively permeable.  The buccal mucosa offers several advantages for controlled drug delivery f.....

No Of Pages : 70
Publication Date: Oct, 2015
Single User Price : US$ 3,000.00

Overview The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative.  It pains most of the companies - whether generic or innovator.  The most of the companies are revalidating their domestic (and thus overseas) strategies to ado.....

No Of Pages : 153
Publication Date: Jan, 2015
Single User Price : US$ 2,000.00

Overview With the recent development, Sri Lanka’s aim of developing a pharma industry should be to penetrate the global market since the internal market is not sufficient for any big firm to operate at optimum levels.  According to a report published by Indian Council.....

No Of Pages : 29
Publication Date: Jan, 2015
Single User Price : US$ 2,000.00

Overview Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition In the recent years several new therapies have been approved in the area of diabetes (SGLT-.....

No Of Pages : 63
Publication Date: Jan, 2015
Single User Price : US$ 2,000.00

Overview All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) and Celgene (CELG), in past year, have given a positive return and hence increased the interest of biotech investors.  These companies have been able to select therapy/niche indication where th.....

No Of Pages : 90
Publication Date: Jan, 2015
Single User Price : US$ 2,000.00

Overview While targeting unmet needs in the treatment of hematological malignancies/ cancer through innovative drug development strategies have witnessed favorable outcomes, the specific choice of the therapies is dependent on the identification of important genomic alterations .....

No Of Pages : 82
Publication Date: Jan, 2015
Single User Price : US$ 3,000.00

Overview The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous efforts by the JP government to promote increased use of gener.....

No Of Pages : 65
Publication Date: Jan, 2015
Single User Price : US$ 4,000.00

Overview Increasing rate of chronic diseases has emphasized the need of Prevention over Intervention.  These proactive health solutions include nutritional supplements which promise medical or health benefits and fall between the food and pharma chain – ‘Nutrace.....

No Of Pages : 62
Publication Date: Jan, 2015
Single User Price : US$ 2,000.00

Overview Traditionally Innovation and drug discovery had taken a back seat in the Indian pharma industry with a few blips here and there. However, there have a been a new generation of entrepreneurs who have  who ventured into the drug discovery  path  backed by V.....

No Of Pages : 22
Publication Date: Jan, 2015
Single User Price : US$ 1,000.00

Overview Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Re.....

No Of Pages : 72
Publication Date: Jan, 2015
Single User Price : US$ 2,000.00

Overview Pain is the leading cause of disability in the US, affecting more than cancer, diabetes and heart disease combined. Current analgesics for persistent pain are relatively ineffective, are associated with significant adverse effects or abuse liability, and do not reduce p.....

No Of Pages : 65
Publication Date: Jan, 2015
Single User Price : US$ 3,000.00

Overview There are more than 1400 sustained or controlled release drugs have been approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is a.....

No Of Pages : 91
Publication Date: Feb, 2014
Single User Price : US$ 2,500.00